Distant bystander effect of REIC/DKK3 gene therapy through immune system stimulation in thoracic malignancies

Ken Suzawa, Kazuhiko Shien, Huang Peng, Masakiyo Sakaguchi, Masami Watanabe, Shinsuke Hashida, Yuho Maki, Hiromasa Yamamoto, Shuta Tomida, Junichi Sou, Hiroaki Asano, Kazunori Tsukuda, Yasutomo Nasu, Hiromi Kumon, Shinichiro Miyoshi, Shinichi Toyooka

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Reduced expression in immortalized cell (REIC)/Dickkoph-3 (DKK3) is a tumor-suppressor gene, and its overexpression by adenovirus vector (Ad-REIC) exhibits a remarkable therapeutic effect on various human cancer types through a mechanism triggered by endoplasmic reticulum stress. Materials and Methods: We examined the direct anti-tumor effect of Ad-REIC gene therapy on lung cancer and malignant mesothelioma cell lines in vitro, and the distant bystander effect using immunocompetent mouse allograft models with bilateral flank tumors. Results: Ad-REIC treatment showed antitumor effect in many lung cancer and malignant mesothelioma cell lines in vitro. In an in vivo model, Ad-REIC treatment inhibited the growth not only of directly treated tumors but also of distant untreated tumors. By immunohistochemical analysis, infiltration of T-cells and natural killer (NK) cells and expression of the major histocompatibility complex (MHC) class I molecules were observed in bilateral tumors. Conclusion: Ad-REIC treatment not only had a direct antitumor effect but also an indirect bystander effect through stimulation of the immune system.

Original languageEnglish
Pages (from-to)301-308
Number of pages8
JournalAnticancer Research
Volume37
Issue number1
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Bystander Effect
Genetic Therapy
Immune System
Thorax
Neoplasms
Lung Neoplasms
Cell Line
Endoplasmic Reticulum Stress
Therapeutic Uses
Cell- and Tissue-Based Therapy
Major Histocompatibility Complex
Tumor Suppressor Genes
Adenoviridae
Natural Killer Cells
Allografts
Therapeutics
T-Lymphocytes
Growth

Keywords

  • Bystander effect
  • Gene therapy
  • Lung cancer
  • Mesothelioma
  • REIC/DKK3

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Distant bystander effect of REIC/DKK3 gene therapy through immune system stimulation in thoracic malignancies. / Suzawa, Ken; Shien, Kazuhiko; Peng, Huang; Sakaguchi, Masakiyo; Watanabe, Masami; Hashida, Shinsuke; Maki, Yuho; Yamamoto, Hiromasa; Tomida, Shuta; Sou, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Nasu, Yasutomo; Kumon, Hiromi; Miyoshi, Shinichiro; Toyooka, Shinichi.

In: Anticancer Research, Vol. 37, No. 1, 01.01.2017, p. 301-308.

Research output: Contribution to journalArticle

Suzawa, Ken ; Shien, Kazuhiko ; Peng, Huang ; Sakaguchi, Masakiyo ; Watanabe, Masami ; Hashida, Shinsuke ; Maki, Yuho ; Yamamoto, Hiromasa ; Tomida, Shuta ; Sou, Junichi ; Asano, Hiroaki ; Tsukuda, Kazunori ; Nasu, Yasutomo ; Kumon, Hiromi ; Miyoshi, Shinichiro ; Toyooka, Shinichi. / Distant bystander effect of REIC/DKK3 gene therapy through immune system stimulation in thoracic malignancies. In: Anticancer Research. 2017 ; Vol. 37, No. 1. pp. 301-308.
@article{5a479b836f3844f3a3adc0f87d886750,
title = "Distant bystander effect of REIC/DKK3 gene therapy through immune system stimulation in thoracic malignancies",
abstract = "Background: Reduced expression in immortalized cell (REIC)/Dickkoph-3 (DKK3) is a tumor-suppressor gene, and its overexpression by adenovirus vector (Ad-REIC) exhibits a remarkable therapeutic effect on various human cancer types through a mechanism triggered by endoplasmic reticulum stress. Materials and Methods: We examined the direct anti-tumor effect of Ad-REIC gene therapy on lung cancer and malignant mesothelioma cell lines in vitro, and the distant bystander effect using immunocompetent mouse allograft models with bilateral flank tumors. Results: Ad-REIC treatment showed antitumor effect in many lung cancer and malignant mesothelioma cell lines in vitro. In an in vivo model, Ad-REIC treatment inhibited the growth not only of directly treated tumors but also of distant untreated tumors. By immunohistochemical analysis, infiltration of T-cells and natural killer (NK) cells and expression of the major histocompatibility complex (MHC) class I molecules were observed in bilateral tumors. Conclusion: Ad-REIC treatment not only had a direct antitumor effect but also an indirect bystander effect through stimulation of the immune system.",
keywords = "Bystander effect, Gene therapy, Lung cancer, Mesothelioma, REIC/DKK3",
author = "Ken Suzawa and Kazuhiko Shien and Huang Peng and Masakiyo Sakaguchi and Masami Watanabe and Shinsuke Hashida and Yuho Maki and Hiromasa Yamamoto and Shuta Tomida and Junichi Sou and Hiroaki Asano and Kazunori Tsukuda and Yasutomo Nasu and Hiromi Kumon and Shinichiro Miyoshi and Shinichi Toyooka",
year = "2017",
month = "1",
day = "1",
doi = "10.21873/anticanres.11321",
language = "English",
volume = "37",
pages = "301--308",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Distant bystander effect of REIC/DKK3 gene therapy through immune system stimulation in thoracic malignancies

AU - Suzawa, Ken

AU - Shien, Kazuhiko

AU - Peng, Huang

AU - Sakaguchi, Masakiyo

AU - Watanabe, Masami

AU - Hashida, Shinsuke

AU - Maki, Yuho

AU - Yamamoto, Hiromasa

AU - Tomida, Shuta

AU - Sou, Junichi

AU - Asano, Hiroaki

AU - Tsukuda, Kazunori

AU - Nasu, Yasutomo

AU - Kumon, Hiromi

AU - Miyoshi, Shinichiro

AU - Toyooka, Shinichi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: Reduced expression in immortalized cell (REIC)/Dickkoph-3 (DKK3) is a tumor-suppressor gene, and its overexpression by adenovirus vector (Ad-REIC) exhibits a remarkable therapeutic effect on various human cancer types through a mechanism triggered by endoplasmic reticulum stress. Materials and Methods: We examined the direct anti-tumor effect of Ad-REIC gene therapy on lung cancer and malignant mesothelioma cell lines in vitro, and the distant bystander effect using immunocompetent mouse allograft models with bilateral flank tumors. Results: Ad-REIC treatment showed antitumor effect in many lung cancer and malignant mesothelioma cell lines in vitro. In an in vivo model, Ad-REIC treatment inhibited the growth not only of directly treated tumors but also of distant untreated tumors. By immunohistochemical analysis, infiltration of T-cells and natural killer (NK) cells and expression of the major histocompatibility complex (MHC) class I molecules were observed in bilateral tumors. Conclusion: Ad-REIC treatment not only had a direct antitumor effect but also an indirect bystander effect through stimulation of the immune system.

AB - Background: Reduced expression in immortalized cell (REIC)/Dickkoph-3 (DKK3) is a tumor-suppressor gene, and its overexpression by adenovirus vector (Ad-REIC) exhibits a remarkable therapeutic effect on various human cancer types through a mechanism triggered by endoplasmic reticulum stress. Materials and Methods: We examined the direct anti-tumor effect of Ad-REIC gene therapy on lung cancer and malignant mesothelioma cell lines in vitro, and the distant bystander effect using immunocompetent mouse allograft models with bilateral flank tumors. Results: Ad-REIC treatment showed antitumor effect in many lung cancer and malignant mesothelioma cell lines in vitro. In an in vivo model, Ad-REIC treatment inhibited the growth not only of directly treated tumors but also of distant untreated tumors. By immunohistochemical analysis, infiltration of T-cells and natural killer (NK) cells and expression of the major histocompatibility complex (MHC) class I molecules were observed in bilateral tumors. Conclusion: Ad-REIC treatment not only had a direct antitumor effect but also an indirect bystander effect through stimulation of the immune system.

KW - Bystander effect

KW - Gene therapy

KW - Lung cancer

KW - Mesothelioma

KW - REIC/DKK3

UR - http://www.scopus.com/inward/record.url?scp=85007591226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007591226&partnerID=8YFLogxK

U2 - 10.21873/anticanres.11321

DO - 10.21873/anticanres.11321

M3 - Article

C2 - 28011506

AN - SCOPUS:85007591226

VL - 37

SP - 301

EP - 308

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1

ER -